We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 111

The USMCA: What does it mean for patents and the pharmaceutical industry?
  • Gowling WLG
  • USA, Canada
  • October 5 2018

In a joint statement on September 30, 2018, the United States and Canadian Governments announced that they reached an agreement, alongside Mexico, on


Health Canada invites public comments on new post-market reporting regulations
  • Gowling WLG
  • USA, Canada
  • August 9 2018

The medical device industry in America and perceived shortcomings in the US Food and Drug Administration's ("FDA") approval process have recently come


A Tale of Two Countries: Patent Eligibility Requirements For Natural Products In Canada And The U.S.
  • Gowling WLG
  • USA, Canada
  • March 28 2018

Natural products - chemical compounds produced by living organisms - are ubiquitous in our daily lives and fundamental to the modern life-sciences


Supreme Court of Canada Bulletin - December 14, 2017
  • Gowling WLG
  • USA, Canada
  • December 14 2017

On appeal from a judgment of the British Columbia Court of Appeal (2016 BCCA 200), setting aside in part a decision of Brown J. (2015 BCSC 1170)...


Why combatting cyber-crime is critical for life science companies
  • Gowling WLG
  • USA
  • April 27 2017

Biotech and pharmaceutical firms hold vast amounts of valuable data and information making them prime targets for cyber-attacks - so how are they


What Brexit means for health products
  • Gowling WLG
  • USA, United Kingdom, European Union
  • January 11 2017

While concern undoubtedly persists across the board about the potential business implications of Britain leaving the EU, it appears that US health


Coming soon to Canadian medical device manufacturers? “Failure to train" cases south of the border
  • Gowling WLG
  • USA, Canada
  • December 21 2016

Medical device manufacturers (“MDMs”) often have to defend against novel theories of liability put forward by plaintiff counsel. The most recent


Guide to Doing Business in Canada
  • Gowling WLG
  • USA, United Kingdom, OECD, Canada, Global
  • October 14 2016

Unlike the United States, Canada was not created by a unilateral declaration of independence from the colonial occupation of England. There was no


Labelling of raw milk cheese
  • Gowling WLG
  • USA, Canada
  • September 12 2016

The science keeps piling up. It is not safe to consume raw milk and its products. The U.S. Food and Drug Administration (FDA) recently announced


3D-printed food when will the laws take shape?
  • Gowling WLG
  • USA, Canada
  • September 12 2016

3D printing is the new buzz technology being used to replicate human tissues, fighter jet parts, and human prosthetics. The technology is also